As someone who works in pre-clinical pharma research, thank god someone is doing this. Projects get killed because they would lead to a drug that would require

As someone who works in pre-clinical pharma research, thank god someone is doing this. Projects get killed because they would lead to a drug that would require very expensive clinical trials. Often, this is because the patient population is hard to identify before they get very sick. Also, I think 23andMe should be very clear that this is what they do, but it isn't inherently problematic. People shouldn't ever be surprised by getting asked to be in a clinical trial based on their information stored at 23andMe.